Clinical Trials
All Clinical Trials - Page 40 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01664676Phase 4Completed
Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients
Liraglutide
- NCT01783717N/AUnknown
Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
Exenatide
- NCT01825148N/ACompleted
GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
Exenatide
- NCT01747200N/ACompleted
Effects of Transcranial Magnetic Stimulation on Object Recognition
Selank
- NCT01541215Phase 3Completed
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Liraglutide
- NCT01722266Phase 3Completed
Liraglutide in the Treatment of Type 1 Diabetes Mellitus
Liraglutide
- NCT01722240Phase 3Completed
Liraglutide in Type 1 Diabetes
Liraglutide
- NCT01754818Phase 1Completed
A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)
Elamipretide
- NCT01714648Phase 4Terminated
Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?
Gonadorelin
- NCT01978873Phase 3Unknown
Efficacy Study Evaluating Chemotherapy in Prostate Cancer
Gonadorelin
- NCT01722227Phase 3Withdrawn
Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
Liraglutide
- NCT01750346Phase 2Terminated
Acetyl Hexapeptide-8 for Blepharospasm
Argireline
- NCT01664247Phase 3Completed
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Liraglutide
- NCT01642732Phase 1Terminated
Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer
Gonadorelin
- NCT01712230N/ACompleted
Females, Aging, Metabolism, and Exercise
Gonadorelin
- NCT01638260Phase 4Terminated
GLP-1 and Non-exercise Activity Thermogenesis in RHZ
Liraglutide
- NCT01573806Phase 1/Phase 2Withdrawn
Pharmacology of Exenatide in Pediatric Sepsis
Exenatide
- NCT01636505Phase 3Unknown
The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol
Gonadorelin
- NCT01767389N/ACompleted
Glucagon-like Peptide (GLP) Utilization and Safety
Liraglutide
- NCT01617434Phase 3Completed
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Liraglutide
- NCT01724060N/ACompleted
Effects of Obesity Treatments on Food Preferences and Metabolism
Liraglutide
- NCT01676116Phase 3Completed
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
Liraglutide
- NCT01618162Phase 3Completed
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Liraglutide
- NCT01628445Phase 3Terminated
Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
Liraglutide
- NCT01499108Phase 4Completed
Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes
Liraglutide
- NCT01677104N/ACompleted
The Microvascular Function of GLP-1 and Its Analogues
Liraglutide
- NCT01610934Phase 2/Phase 3Completed
The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
Liraglutide
- NCT01667900Phase 1Completed
A Study of Dulaglutide in Chinese Participants
Dulaglutide
- NCT01524705Phase 4Completed
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Exenatide
- NCT01776788Phase 4Completed
Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
Exenatide
- NCT01642186Phase 2Completed
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
Gonadorelin
- NCT02721888Phase 4Terminated
Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
Liraglutide
- NCT01732068Phase 2Completed
Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol
Gonadorelin
- NCT02022228N/AUnknown
Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome
Gonadorelin
- NCT01656161Phase 3Completed
Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer
Gonadorelin
- NCT01669291N/ACompleted
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
Gonadorelin
- NCT01603420Phase 2/Phase 3Terminated
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Gonadorelin
- NCT01658501Phase 2Completed
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Liraglutide
- NCT01795248Phase 4Completed
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
Liraglutide
- NCT01644500Phase 3Completed
A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
Dulaglutide
- NCT01621178Phase 3Completed
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Dulaglutide
- NCT01648582Phase 3Completed
A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
Dulaglutide
- NCT01664624Phase 1Completed
Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
Exenatide
- NCT01620489Phase 3Completed
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Liraglutide
- NCT01557166Phase 3Completed
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Liraglutide
- NCT01667406Phase 2Completed
The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment
Kisspeptin
- NCT01619345Phase 1Completed
Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects
Semaglutide
- NCT01591902Phase 4Terminated
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Tesamorelin
- NCT01597531Phase 4Terminated
Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
Liraglutide
- NCT01612468Phase 4Completed
Liraglutide in Type 1 Diabetes
Liraglutide